U.S. MARKETS FOR DRUG AND FLUID DELIVERY DEVICES

277 Pages | 73 Exhibits | 2012 Analysis | Forecasts Through 2016

OVERVIEW:
Pharmacotherapy represents the first-line treatment in the management of most chronic and transient medical conditions warranting therapeutic intervention in the U.S. To date, more than 40,000 prescription drug products containing 2,700 active ingredients have been approved by the FDA; these products accounted for more than 70% of the national pharmaceutical usage in 2011. In the same year, U.S. pharmacies processed approximately 3.6 billion prescriptions, generating an estimated $300.0 billion in cumulative pharmaceutical sales and representing nearly 12.5% of the nation's total healthcare spending. This report covers injection/infusion, transdermal, and inhalation drug delivery devices. In 2011, U.S. sales of these devices totalled nearly $22 billion; over the forecast period covered by this report, sales are expected to increase at a compound annual rate of 5.4%, reaching more than $28 billion in the year 2016.

This new report by Medtech Insight presents a detailed overview of the U.S. drug and fluid delivery devices market. Major topics covered by this report include an overview of drug delivery technologies, injection/infusion drug delivery systems (e.g., syringes, injection pens, needleless jet injectors, infusion pumps and disposables, gravity infusion systems, and vascular access devices), transdermal drug delivery systems (e.g., patch-based pharmaceutical products for cardiovascular disease management, central nervous system disorder management, hormone replacement therapy, acute and chronic pain management, and urologic disorder management), and inhalation drug delivery systems (e.g., inhaled insulin delivery systems and inhaled respiratory drug systems such as dry powder inhaler- and metered dose inhaler-based preparations for the treatment of asthma, chronic obstructive pulmonary disease, and cystic fibrosis).

TABLE OF CONTENTS:
EXECUTIVE SUMMARY

i. Injection/Infusion Drug Delivery Systems
ii. Transdermal Drug Delivery Systems
iii. Inhalation Drug Delivery Systems
iv. Combined Market Forecast

Exhibit ES-1: Injection/Infusion Drug Delivery Systems, Market Forecast, 2011-2016
Exhibit ES-2: Patch-Based Transdermal Pharmaceutical Products, Market Forecast, 2011-2016
Exhibit ES-3: Inhalation Drug Delivery Products, Market Forecast, 2011-2016
Exhibit ES-4: Drug and Fluid Delivery Devices, Combined Market Forecast, 2011-2016

1. OVERVIEW OF DRUG DELIVERY

1.1 Oral Drug Delivery
	1.1.1 Access Pharmaceuticals
	1.1.2 Emisphere Technologies
	1.1.3 Lipocine
1.2 Transdermal Drug Delivery
1.3 Transmucosal Drug Delivery
	1.3.1 Generex Biotechnology
1.4 Inhalation Drug Delivery
1.5 Injection/Infusion Drug Delivery
	1.5.1 Injection
	1.5.2 Infusion
		1.5.2.1 Intraoperative Site Infusion
		1.5.2.2 Intraperitoneal/Transperitoneal Infusion
		1.5.2.3 Intraspinal Infusion
		1.5.2.4 Intravascular Infusion

Exhibit 1-1: Advantages and Disadvantages of Selected Drug Delivery Methods

2. INJECTION/INFUSION DRUG DELIVERY SYSTEMS

2. Injection/Infusion drug delivery systems
2.1 Clinical Applications
	2.1.1 Anesthesia Therapy
	2.1.2 Antibiotic/Antiviral Therapy
	2.1.3 Bone Marrow Transplant Therapy
	2.1.4 Organ Transplant Therapy
	2.1.5 Cardiovascular Disease Infusion Therapy
		2.1.5.1 Anticoagulant and Thrombolytic Therapy
		2.1.5.2 Heart Failure Management
	2.1.6 Chemotherapy
	2.1.7 Diabetes Management
	2.1.8 Hydration Therapy
	2.1.9 Nutritional Support
		2.1.9.1 Total Parenteral Nutrition
		2.1.9.2 Enteral Nutrition
	2.1.10 Pain Management
	2.1.11 Transfusion Therapy
	2.1.12 Other Infusion-Based Drug Therapies
		2.1.12.1 Cytokine Therapy
		2.1.12.2 Growth Hormone Therapy
		2.1.12.3 Interferon Therapy
		2.1.12.4 Infertility Therapy
		2.1.12.5 High-Risk Pregnancy Management
		2.1.12.6 Perinatal Therapy
2.2 Products and Technologies
	2.2.1 Syringe Products
		2.2.1.1 Multipurpose Standard Syringes
		2.2.1.2 Multipurpose Safety Syringes
		2.2.1.3 Insulin Syringes
		2.2.1.4 Market Analysis
		2.2.1.5 Competitive Analysis
	2.2.2 Injection Pen Products
		2.2.2.1 Market Analysis
		2.2.2.2 Competitive Analysis
	2.2.3 Needleless Jet Injector Products
		2.2.3.1 Market Analysis
		2.2.3.2 Competitive Analysis
	2.2.4 Infusion Pump Products
		2.2.4.1 Volumetric Pumps
			2.2.4.1.1 Market Analysis
			2.2.4.1.2 Competitive Analysis
		2.2.4.2 Syringe Pumps
			2.2.4.2.1 Market Analysis
			2.2.4.2.2 Competitive Analysis
		2.2.4.3 Ambulatory Pumps
			2.2.4.3.1 Market Analysis
			2.2.4.3.2 Competitive Analysis
		2.2.4.4 Disposable Pumps
			2.2.4.4.1 Market Analysis
			2.2.4.4.2 Competitive Analysis
		2.2.4.5 Implantable Pumps
			2.2.4.5.1 Market Analysis
			2.2.4.5.2 Competitive Analysis
		2.2.4.6 Insulin Pumps
			2.2.4.6.1 Market Analysis
			2.2.4.6.2 Competitive Analysis
		2.2.4.7 Enteral Pumps and Gravity Systems
			2.2.4.7.1 Market Analysis
			2.2.4.7.2 Competitive Analysis
		2.2.4.8 Intravascular Gravity Infusion Systems
			2.2.4.8.1 Market Analysis
			2.2.4.8.2 Competitive Analysis
	2.2.5 Vascular Access Products
		2.2.5.1 Short Peripheral Catheters
			2.2.5.1.1 Market Analysis
			2.2.5.1.2 Competitive Analysis
		2.2.5.2 Midline Catheters
			2.2.5.2.1 Market Analysis
			2.2.5.2.2 Competitive Analysis
		2.2.5.3 Peripherally Inserted Central Catheters
			2.2.5.3.1 Market Analysis
			2.2.5.3.2 Competitive Analysis
		2.2.5.4 Central Venous Catheters
			2.2.5.4.1 Market Analysis
			2.2.5.4.2 Competitive Analysis
		2.2.5.5 Implantable Ports
			2.2.5.5.1 Market Analysis
			2.2.5.5.2 Competitive Analysis

Exhibit 2-1: Injection/Infusion Drug Delivery Systems, Combined Market Forecast, 2011-2016
Exhibit 2-2: 2012, Selected Safety Syringes
Exhibit 2-3: 2012, Selected Insulin Syringes
Exhibit 2-4: Multipurpose and Insulin Syringes, Market Forecast 2011-2016
Exhibit 2-5: 2011, Multipurpose and Insulin Syringes Market, Share by Supplier
Exhibit 2-6: 2012, Selected Insulin Pens
Exhibit 2-7: Insulin Pen Products, Market Forecast, 2011-2016
Exhibit 2-8: 2011, Insulin Pen Products Market, Share by Supplier
Exhibit 2-9: 2012, Selected Needleless Jet Injectors
Exhibit 2-10: Needleless Jet Injectors, Market Forecast, 2011-2016
Exhibit 2-11: 2011, Needleless Jet Injectors Market, Share by Supplier
Exhibit 2-12: Infusion Pumps, Combined Market Forecast, 2011-2016
Exhibit 2-13: 2012, Selected Volumetric Pumps
Exhibit 2-14: Volumetric Pumps and Disposables, Market Forecast, 2011-2016
Exhibit 2-15: 2011, Volumetric Pumps and Disposables Market, Share by Supplier
Exhibit 2-16: 2012, Selected Syringe Pumps
Exhibit 2-17: Syringe Pumps and Disposables, Market Forecast, 2011-2016
Exhibit 2-18: 2011, Syringe Pumps and Disposables Market, Share by Supplier
Exhibit 2-19: 2012, Selected Ambulatory Pumps
Exhibit 2-20: Ambulatory Pumps, Market Forecast, 2011-2016
Exhibit 2-21: 2011, Ambulatory Pumps and Disposables Market, Share by Supplier
Exhibit 2-22: 2012, Selected Disposable Infusion Pumps
Exhibit 2-23: Disposable Infusion Pumps, Market Forecast, 2011-2016
Exhibit 2-24: 2011, Disposable Infusion Pumps Market, Share by Supplier
Exhibit 2-25: Implantable Infusion Pumps, Market Forecast, 2011-2016
Exhibit 2-26: 2011, Implantable Infusion Pumps Market, Share by Supplier
Exhibit 2-27: 2012, Selected Insulin Pumps
Exhibit 2-28: Insulin Pumps and Disposables, Market Forecast, 2011-2016
Exhibit 2-29: 2011, Insulin Pumps and Disposables Market, Share by Supplier
Exhibit 2-30: 2012, Selected Enteral Nutrition Pumps
Exhibit 2-31: Enteral Pumps, Disposables, and Gravity Sets, Market Forecast, 2011-2016
Exhibit 2-32: 2011, Enteral Pumps, Disposables, and Gravity Sets Market, Share by Supplier
Exhibit 2-33: Intravenous Gravity Infusion Systems, Market Forecast, 2011-2016
Exhibit 2-34: 2011, Intravenous Gravity Infusion Systems Market, Share by Supplier
Exhibit 2-35: 2012, Selected Vascular Access Devices
Exhibit 2-36: Vascular Access Devices, Combined Market Forecast, 2011-2016
Exhibit 2-37: Short Peripheral Catheters, Market Forecast, 2011-2016
Exhibit 2-38: 2011, Short Peripheral Catheters Market, Share by Supplier
Exhibit 2-39: Midline Catheters, Market Forecast, 2011-2016
Exhibit 2-40: 2011, Midline Catheters Market, Share by Supplier
Exhibit 2-41: Peripherally Inserted Central Catheters, Market Forecast, 2011-2016
Exhibit 2-42: 2011, Peripherally Inserted Central Catheters Market, Share by Supplier
Exhibit 2-43: Central Venous Catheters, Market Forecast, 2011-2016
Exhibit 2-44: 2011, Central Venous Catheters Market, Share by Supplier
Exhibit 2-45: Implantable Ports, Market Forecast, 2011-2016
Exhibit 2-46: 2011, Implantable Ports Market, Share by Supplier

3. TRANSDERMAL DRUG DELIVERY SYSTEMS

3.1 Technology
	3.1.1 Passive Transdermal Transport Systems
		3.1.1.1 3M Health Care/3M
		3.1.1.2 NanoPass Technologies
		3.1.1.3 Zosano Pharma
	3.1.2 Active Transdermal Transport Systems
		3.1.2.1 Echo Therapeutics
		3.1.2.2 Inovio Pharmaceuticals
		3.1.2.3 IOMED/DJO
		3.1.2.4 Teikoku Pharma
		3.1.2.5 Vyteris
3.2 Clinical Applications
	3.2.1 Cardiovascular Disease Management
		3.2.1.1 Products
		3.2.1.2 Market Analysis
		3.2.1.3 Competitive Analysis
	3.2.2 Central Nervous System Disorder Management
		3.2.2.1 Products
		3.2.2.2 Market Analysis
		3.2.2.3 Competitive Analysis
	3.2.3 Hormone Replacement Therapy
		3.2.3.1 Products
		3.2.3.2 Market Forecast
		3.2.3.3 Competitive Analysis
	3.2.4 Pain Management
		3.2.4.1 Cancer-Related Pain
		3.2.4.2 Post-Herpetic Neuralgia
		3.2.4.3 Products
		3.2.4.4 Market Analysis
		3.2.4.5 Competitive Analysis
	3.2.5 Urologic Disorder Management
		3.2.5.1 Products
		3.2.5.2 Market Analysis

Exhibit 3-1: 2012, Selected Microneedle Array Systems
Exhibit 3-2: 2012, Selected Directed Energy-Assisted Transdermal Macromolecular Transport Products
Exhibit 3-3: Patch-Based Pharmaceutical Products, by Application, Combined Market Forecast, 2011-2016
Exhibit 3-4: 2012, Selected Patch-Based Clonidine and Nitroglycerin Products
Exhibit 3-5: Patch-Based Clonidine and Nitroglycerin Products, Market Forecast, 2011-2016
Exhibit 3-6: 2011, Patch-Based Clonidine and Nitroglycerin Products Market, Share by Supplier
Exhibit 3-7: 2012, Selected Patch-Based Central Nervous System Treatment Products
Exhibit 3-8: Patch-Based Central Nervous System Disorder Treatment Products, Market Forecast, 2011-2016
Exhibit 3-9: 2011, Patch-Based Central Nervous System Disorder Treatment Products Market, Share by Supplier
Exhibit 3-10: 2012, Selected Patch-Based Estrogen Replacement Products
Exhibit 3-11: Patch-Based Estrogen Replacement Products, Market Forecast, 2011-2016
Exhibit 3-12: 2011, Patch-Based Estrogen Replacement Products Market, Share by Supplier
Exhibit 3-13: 2012, Selected Patch-Based Pain Management Products
Exhibit 3-14: Patch-Based Pain Management Products, Market Forecast, 2011-2016
Exhibit 3-15: 2011, Patch-Based Pain Management Products Market, Share by Supplier
Exhibit 3-16: 2012, Selected Patch-Based Urologic Treatment Products
Exhibit 3-17: Patch-Based Urologic Treatment Products, Market Forecast, 2011-2016

4. INHALATION DRUG DELIVERY SYSTEMS

4.1 Chronic Respiratory Disorder Management
	4.1.1 Bronchial Asthma
	4.1.2 Chronic Bronchitis
	4.1.3 Pulmonary Emphysema
	4.1.4 Cystic Fibrosis
	4.1.5 Obstructive Pulmonary Disorder Management
		4.1.5.1 Allergy-Blocking Agents
		4.1.5.2 Anti-Inflammatory Agents
		4.1.5.3 Bronchodilators
4.2 Diabetes Management
4.3 Emerging Applications
	4.3.1 Alkermes
	4.3.2 Aradigm
	4.3.3 MannKind
	4.3.4 Nektar Therapeutics
4.4 Technology
	4.4.1 Metered Dose Inhalers
		4.4.1.1 Breath-Actuated Metered Dose Inhalers
		4.4.1.2 Chlorofluorocarbon-Free Metered Dose Inhalers
		4.4.1.3 Spacers for Use with Metered Dose Inhalers
	4.4.2 Dry Powder Inhalers
	4.4.3 Nebulizers
4.5 Products
4.6 Market Analysis
4.7 Competitive Analysis

Exhibit 4-1: 2012, Selected Inhalation Therapy Agents
Exhibit 4-2: Advantages and Disadvantages of Inhalation Drug Delivery Devices
Exhibit 4-3: 2012, Selected Dry Powder Inhalers and Metered Dose Inhalers
Exhibit 4-4: Inhalation Drug Delivery Products, Market Forecast, 2011-2016
Exhibit 4-5: 2011, Inhalation Respiratory Drug Delivery Products Market, Share by Supplier

5. COMPANY PROFILES

5.1 Abbott Laboratories
5.2 C.R. Bard, Inc.
5.3 Baxter Healthcare Corporation/Baxter International, Inc.
5.4 Bayer AG
5.5 BD (Becton, Dickinson and Company)
5.6 Bioject Medical Technologies, Inc.
5.7 Boehringer Ingelheim GmbH
5.8 B. Braun Melsungen AG
5.9 CareFusion Corporation
5.10 Endo Pharmaceuticals Holdings, Inc.
5.11 GlaxoSmithKline PLC
5.12 Hospira, Inc.
5.13 I-Flow Corporation/Kimberly-Clark Corporation
5.14 Johnson & Johnson
5.15 Kendall Healthcare/Covidien LTD
5.16 Medtronic, Inc.
5.17 Merck & Co., Inc.
5.18 Mylan Laboratories, Inc.
5.19 Novartis AG
5.20 Noven Pharmaceuticals, Inc./Hisamitsu Pharmaceutical Co., Inc.
5.21 Novo Nordisk AS
5.22 Smiths Medical, Inc./Smiths Group PLC
5.23 Teleflex Medical, Inc./Teleflex, Inc.

APPENDIX: COMPANY LISTING



COMPANIES COVERED:

  1. 3M Health Care/3M
  2. Abbott Laboratories
  3. Abbott Nutrition/ Abbott Laboratories
  4. Access Pharmaceuticals, Inc.
  5. Acrux LTD
  6. Actavis, Inc.
  7. Activa Brand Products, Inc.
  8. Adherex Technologies, Inc.
  9. Aerogen, Inc.
  10. Alkermes PLC
  11. AngioDynamics, Inc.
  12. Animas Corporation/ Johnson & Johnson
  13. Antares Pharma, Inc.
  14. Apotex, Inc.
  15. A.P. Pharma, Inc.
  16. Apricus Biosciences, Inc.
  17. Aradigm Corporation
  18. AstraZeneca PLC
  19. C.R. Bard, Inc.
  20. Baxa Corporation/ Baxter International, Inc.
  21. Baxter Healthcare Corporation/ Baxter International, Inc.
  22. Bayer HealthCare/ Bayer AG
  23. BD (Becton, Dickinson and Company)
  24. Bioject Medical Technologies, Inc.
  25. Boehringer Ingelheim GmbH
  26. B. Braun Melsungen AG
  27. CareFusion Corporation
  28. CME America LLC
  29. Codman & Shurtleff, Inc./ Johnson & Johnson
  30. Cook Medical/ Cook Group, Inc.
  31. CORPAK MedSystems, Inc./ Linden Capital Partners LLC
  32. Covidien PLC
  33. Delta Hi-Tech, Inc.
  34. Echo Therapeutics, Inc.
  35. Elan Corporation PLC
  36. Eli Lilly and Company
  37. Emisphere Technologies, Inc.
  38. Endo Pharmaceuticals Holdings, Inc.
  39. Forest Laboratories, Inc.
  40. Generex Biotechnology Corporation
  41. GlaxoSmithKline PLC
  42. Hospira, Inc.
  43. I-Flow Corporation/ Kimberly-Clark Corporation
  44. Inovio Pharmaceuticals, Inc.
  45. Insulet Corporation
  46. International Technology Group
  47. IOMED, Inc./ DJO, Inc.
  48. Janssen Pharmaceuticals, Inc./ Johnson & Johnson
  49. Johnson & Johnson
  50. Kawasumi Laboratories America, Inc./ Kawasumi Laboratories, Inc.
  51. Kendall Healthcare/ Covidien LTD
  52. Kos Pharmaceuticals, Inc./ Abbott Laboratories
  53. Lipocine, Inc.
  54. MannKind Corporation
  55. MediCore, Inc.
  56. Medtronic, Inc.
  57. Merck & Co., Inc.
  58. MicroDose Therapeutx, Inc.
  59. mdtx.com
  60. Moog, Inc.
  61. Mylan Laboratories, Inc.
  62. NanoPass Technologies LTD
  63. National Medical Products, Inc.
  64. Nektar Therapeutics, Inc.
  65. Nestle Group
  66. Novartis AG
  67. Noven Pharmaceuticals, Inc./ Hisamitsu Pharmaceutical Co., Inc.
  68. Novo Nordisk A/S
  69. Owen Mumford LTD
  70. PenJet Corporation
  71. PharmaJet, Inc.
  72. QLT, Inc.
  73. Repro-Med Systems, Inc. (dba RMS Medical Products)
  74. Retractable Technologies, Inc.
  75. Robbins Instruments, Inc.
  76. Roche Diagnostics/ F. Hoffman-La Roche LTD
  77. Sandoz/ Novartis AG
  78. sanofi-aventis SA
  79. Smiths Medical, Inc./ Smiths Group PLC
  80. Sol-Millennium Medical, Inc./ Sol-Millennium Group
  81. Sooil USA/ Sooil Development Co., LTD
  82. Sunovion Pharmaceuticals, Inc./ Dainippon Sumitomo Pharma Co., LTD
  83. Teikoku Pharma, Inc.
  84. Teleflex Medical, Inc./ Teleflex, Inc.
  85. Terumo Medical Corporation/ Terumo Corporation
  86. Teva Pharmaceuticals/ Teva Pharmaceutical Industries LTD
  87. UltiMed, Inc.
  88. U.S. Medical Instruments, Inc.
  89. Vectura Group PLC
  90. Vyteris, Inc./ Vyteris Holdings, Inc.
  91. WalkMed Infusion LLC
  92. Watson Pharmaceuticals, Inc.
  93. Zosano Pharma, Inc.
Contact Us

Need help finding medtech research? Let us help you!